Drug Type Chemical drugs |
Synonyms |
Mechanism B1 receptor antagonists(Bradykinin B1 receptor antagonists), B2 receptor antagonists(Bradykinin B2 receptor antagonists) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhaseDiscontinuedPreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC115H173N33O28S2 |
InChIKeyBQKCDYMOCIAHQH-UHFFFAOYSA-N |
CAS Registry145996-18-5 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Inflammation | Preclinical | US | - |